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Occupational allergy to Artemia fish fry feed in aquaculture
Background Artemia (brine shrimp) is used as feed for fish fry and shrimp in aquaculture. Two employees in a Norwegian aquaculture research farm reported having chest symptoms when working in an Artemia hatch room.
Aims
To determine the presence and prevalence of Artemia sensitization at the farm and the extent of any Artemia-related respiratory and hand skin symptoms and to identify the allergens involved.
Methods
Participants completed a questionnaire and structured interview. Skin prick tests (SPTs) were performed, and immunoglobulin E (IgE) antibodies to Artemia, shrimp and recombinant tropomyosin were determined. Gel electrophoresis and immunoblots of Artemia extracts were also carried out.
Introduction
This study was initiated after two employees reported chest symptoms when working in the hatch room for Artemia in a Norwegian aquaculture research farm. The Artemia genus, also called brine shrimp (order Anostraca, class Branchiopoda and subphylum Crustacea), is used as feed for aquarium fish and fish fry and shrimp in aquaculture throughout the world. Crustaceans, mainly of the order Decapoda and class Malacostraca, such as shrimp, crab, crayfish and lobster, are well-known causes of food and occupational allergies [1] [2] [3] [4] [5] .
The aims of the study were to determine the prevalence of immunoglobulin E (IgE) sensitization to Artemia at the research farm, the extent of respiratory and hand skin symptoms related to Artemia exposure and to identify any Artemia allergens involved.
Methods
Artemia were stored as cysts at the research farm. For a few weeks two to three times each year, new-hatched cod and halibut fry were fed with living Artemia. During these periods, Artemia were hatched and fed in separate tanks in the Artemia hatch room before being used as food. The Artemia tanks contained seawater at 25-27°C. Air was constantly added to the tanks and bubbles induced aerosols. Some employees worked in the hatch room, some fed the fish fry and others joined them in a shift system looking after the whole farm during evenings and weekends.
The entire staff (N 5 42) were invited to participate in a cross-sectional survey. All participants completed a selfadministered questionnaire. One physician, blinded to these questionnaire results, performed a structured interview based on the same questionnaire. The interview gave similar but more extensive information than the questionnaire answers alone and was therefore chosen for further analysis.
The collected information included demographic data, years employed at the farm, when and where subjects worked with Artemia, smoking habits and family history of allergy. Atopy was defined as reported hay fever, a positive skin prick test (SPT) or specific serum IgE to at least one allergen other than Artemia or eye and airway symptoms after contact with tree or grass pollens, animals or house dust.
Questions concerning nose and eye symptoms were taken from the International Study of Asthma and Allergies in Childhood questionnaire [6] . In accordance with international recommendations, rhinitis was defined as at east two of the three symptoms of runny nose, blocked nose or itching/sneezing [7] . Questions about chest symptoms (episodic wheezing, dyspnoea or tightness in the chest and cough) were taken from the Norwegian version [8] of the European Community Respiratory Health Survey [9] .
Artemia-related symptoms were considered to be present when the symptoms occurred during work in the Artemia hatch room or during work with Artemia elsewhere but were absent or reduced during weekends or vacations. Symptoms occurring after work shifts were included. Artemia-related symptoms were further divided into rhinitis, chest symptoms and hand skin eruptions. Subjects who reported Artemia-related symptoms were asked where and when the symptoms first started. If the symptoms had ceased, we explored whether this could be related to reduction or cessation of exposure.
Asthma was defined by answering 'yes' to at least one of the two questions: 'Has a doctor told you you have asthma?' and 'Have you been treated with asthma medicine?' For those with asthma, we noted whether symptoms started before or after the first exposure to Artemia and whether any connection to Artemia-related chest symptoms was present.
SPTs were performed according to the guidelines of the European Academy of Allergology and Clinical Immunology [10] . Both live Artemia directly taken from the hatch tank and Artemia stored at 220°C were used for SPT. Subjects with positive SPT reactions to Artemia were additionally tested with house dust mite (Dermatophagoides pteronyssinus) and shrimp (ALK Abelló , Hørsholm, Denmark). A positive SPT result was defined as a mean duplicate wheal diameter at least 3 mm larger than that of the negative control recorded after 15 min. Positive (histamine hydrochloride 10 mg/ml) and negative controls were supplied by ALK Abelló . SPT was performed by one trained allergy nurse, blinded to the questionnaire results, using a technique that gave a mean histamine wheal diameter of 5.8 mm and a coefficient of variation (standard deviation/mean) for the differences between duplicates (n 5 30) of 0.13.
Serum IgE and IgE antibodies to recombinant tropomyosin, shrimp, Artemia, PhadiatopÒ (a commercial preparation of timothy, birch, olive and mugwort pollen, D.
pteronyssinus, Dermatophagoides farinae, Cladosporium herbarum, dog and horse allergens) and fx5EÒ (hen's egg white, cow's milk, cod, wheat, peanut and soybean) were analysed with the CAP-FEIA system (Phadia AB, Uppsala, Sweden). If either of the allergen panels were positive, IgE antibodies to the individual allergens were reanalysed. Serum IgE and IgE antibody levels were defined as elevated if at least 120 kU/l and 0.35 kUA/l, respectively. Artemia extracts were separated by sodium dodecyl sulphate-polyacrylamide gel electrophoresis and immunodetection was performed as described previously [11] .
IgE reactivities to Artemia were analysed by enzymelinked immunosorbent assay (ELISA) using sera of subjects with positive SPT and IgE to Artemia [11] .
Results were defined as positive if at least 3% of IgE was bound to a protein in Artemia extract and the subject was thereby classified as Artemia sensitized.
Statistical analyses were done with SPSS 14.0 for Windows. Median and range were reported for age, employment and Artemia exposure.
Informed consent was obtained from all participants. The Regional Committee for Medical Research Ethics for Western Norway (REK Vest) and the Norwegian Data Inspectorate of Medical Research approved the study.
Results
Thirty (71%) employees participated, but two refused to give blood samples for serum IgE analyses. Subjects' characteristics including Artemia exposures are shown in Table 1 . The majority of participants could be included in more than one of the Artemia exposure categories. During the study period, 12 participants worked with Artemia and 2 of them in the hatch room. As shown in Table 2 , four Family history of allergy or asthma 16 (53) (17%) of the Artemia-exposed subjects reported having ever had Artemia-related symptoms. Subjects A, C and D (Table 2) reported Artemia-related chest symptoms including dyspnoea and cough in all cases and in addition wheeze in Subject C. Subject D reported Artemia-related runny nose and sneezing classified as rhinitis. One of them (Subject A, Table 2 ) developed doctor-diagnosed asthma after starting work in the hatch room 6 years before the study. Subject E had had childhood asthma. Positive SPTs to Artemia were seen in 25% (6 of 24) of Artemia-exposed subjects ( Table 2) . Four of them (subjects A, B, E and G) demonstrated isolated immediate reactions and two subjects (C and H) reported isolated late-phase reactions after 11 and 24 h. In addition, one non-exposed subject reported a late-phase reaction after 48 h. The 26 subjects with immediate negative SPT results had no detectable reaction in the duplicates. All subjects positive to Artemia had negative SPT to shrimp, but subjects E and G demonstrated immediate SPT reactions to house dust mite. Subjects A, B and E had worked in the hatch room. Table 2 shows that subjects A, B, C, E and F were IgE positive on Artemia ELISA testing; 21 subjects had no detectable IgE binding with this method.
Six of 30 participants (20%) tested positive to common airway allergens (PhadiatopÒ) and one of them also tested positive to common food allergens (fx5EÒ). Four subjects had elevated IgE, but none had IgE antibodies to shrimp or recombinant tropomyosin.
Of subjects reporting Artemia-related symptoms, subjects A, B and C, representing 13% of those exposed (Table  2) , had IgE antibodies to Artemia (ELISA). They also demonstrated positive SPT: two exhibited immediate reactions and one (Subject C) an isolated late-phase response. Subjects A and C reported that chest symptoms had developed during work in the hatch room between a few months and 1 year after starting work there. They have not had chest symptoms since their work in the hatch room ended. Subjects B and C had experienced hand skin eruptions during work in the hatch room between 1 and 3 years after starting work there. Subject B's skin symptoms disappeared after changing to a non-exposed job at the farm. Subject C continued to experience itchy hand skin eruptions when handling Artemia outside the hatch room. None of the Artemia-sensitized subjects had developed new Artemia-related symptoms during the last 5 years.
In total, six (25%) of the Artemia-exposed subjects had either an immediate SPT response or a detectable IgE (ELISA) to native Artemia ( Table 2 ); three of them had both, but only Subject A was also positive to the commercial Artemia ImmunoCAPÒ (Phadia AB). Two of the six (subjects E and G) were also IgE sensitized to common airway allergens (PhadiatopÒ), including house dust mite and Subject G had elevated IgE. The three subjects who reported Artemia-related symptoms showed evidence of sensitization to Artemia alone. Among those subjects who were neither Artemia sensitized nor reported Artemia-related symptoms, 5 had not been exposed to Artemia and 17 had been, 6 of them also in the hatch room.
Immunoblotting with pooled sera from the six Artemiasensitized subjects demonstrated major IgE binding to a protein with a molecular mass of 97 kDa (Figure 1 ).
Discussion
This cross-sectional study demonstrated that 25% of staff exposed to Artemia fish fry feed were IgE sensitized; four (17%) had experienced Artemia-related symptoms of whom three (13%) reported respiratory symptoms.
A strength of this study is that we used three different methods of detecting Artemia sensitization and with two of them (SPT and ELISA) used native Artemia taken from the hatch tank. IgE sensitization to Artemia was defined by either a positive immediate SPT reaction or the presence of IgE antibodies to Artemia measured by ELISA or ImmunoCAPÒ. The presence of isolated 
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immediate SPT reactions in four subjects is highly suggestive of an IgE-mediated mechanism, not least since in three of these specific IgE antibodies were present in serum. Although the study was not designed to record latephase SPT reactions, three subjects spontaneously reported infiltration after 11-48 h. The reactions were present in duplicate, were of considerable size and in two cases were also documented photographically. These late reactions were probably caused by immunological mechanisms, either a delayed IgE-mediated reaction (e.g. in Subject E, who had a high ELISA score) or a non-IgE-mediated reaction (Subject H and the nonexposed subject, in both of whom IgE serum antibodies to Artemia were not detected). Subjects IgE sensitized to Artemia who reported exposure-related respiratory or skin symptoms were taken to represent cases of clinical allergic reactions to Artemia. Using the questionnaire-based definition of chest symptoms probably resulted in high sensitivity but low specificity as an indicator of asthma [12] . Although only Subject A had an asthma diagnosis established by a doctor, Subject C experienced lower airway symptoms, probably of IgE-mediated origin. Hand skin eruptions recorded by the questionnaire may have represented different disease entities, such as protein or allergic contact dermatitis [2, 4] , as well as allergic contact urticaria. However, since both subjects reporting skin reactions were IgE sensitized to Artemia, the latter diagnosis seems more likely. Our symptom questionnaire was not validated clinically, nor were its findings confirmed by exposure or provocation testing, but we think that the use of a standardized questionnaire combined with an interview strengthened the study since the latter collected more information and provided an opportunity to check whether the questionnaire was fully understood.
Several studies have shown that the risk of becoming sensitized and developing allergic airway symptoms increase with the level of allergen in the breathing atmosphere [2, 13, 14] . We anticipated the highest allergen concentration to be in the bioaerosols above the hatch and feed tanks, not least since all the reported Artemiarelated symptoms were related to working there. However, Artemia exposure, as either amount of bioaerosol or allergen concentration in the workplace atmosphere, was not monitored in this study. Direct skin contact with Artemia and thus the risk of becoming skin sensitized also appeared to be highest in the hatch room since all reported Artemia-related skin eruptions first appeared after direct skin contact when working there.
At this particular research farm, most employees worked in the hatch room for a period and then changed to less exposed or non-exposed work tasks without having developed symptoms, but some had become IgE sensitized to Artemia. Others changed to lower exposure or unexposed jobs as a consequence of developing Artemiarelated symptoms. Since symptoms thereby diminished or disappeared, they could continue working at the farm. The healthy worker effect may explain why only one individual reported current Artemia-related symptoms and the extent to which previous and non-participating employees had experienced Artemia-related allergic manifestations is not known.
We noted that none of the Artemia-sensitized subjects had developed new exposure-related symptoms during the previous 5 years. Those who worked in the hatch room during the study period were not Artemia sensitized, in spite of having worked there for at least 6 years, the longest exposure times recorded in the study population. This probably reflects different individual genetic dispositions to sensitization.
The study group was relatively small and only six participants (20%) were non-exposed controls. This limited opportunities for statistical analysis of our results and comparison of different exposure and symptom groups.
The cross-sectional design of this study does not allow confirmation of a causal relationship between occupational exposure, sensitization and clinical symptoms. In order to confirm the consequences of occupational exposure to Artemia, a longitudinal study is required.
The 97-kDa IgE-binding protein from the Artemia extract may be identical to paramyosin, an invertebrate muscle protein. Allergy to crustacean paramyosin is uncommon, and where it is implicated as an allergen other proteins, especially tropomyocin, seem to be more heavily involved [15, 16] . Paramyosin is also one of the proteins binding IgE in subjects allergic to the fish parasite Anisakis simplex [17] and is one of the IgE-binding proteins in mite extracts [18] . To our knowledge, only two case histories of Artemia allergy have been published to date. In one, a technician at a research farm producing fish food containing Artemia and shrimp developed Artemia-related allergic rhinoconjunctivitis and asthma [19] and in the other probable allergic conjunctivitis occurred in an atopic individual using Artemia to feed fish in his hobby aquarium [20] . The exposure conditions in these cases were different from those in our study.
The results from this study support these two case histories in suggesting that Artemia can sensitize and elicit allergic symptoms in exposed workers. In this study population, the ImmunoCapÒ test system showed low sensitivity compared to ELISA and SPT. In 1997, .1500 metric tons of Artemia cysts were used in shrimp and fish hatchery industries [21] and the farm in this study uses 50-100 kg Artemia cysts each year. We believe the potential of Artemia as an occupational allergen in the widespread and rapidly growing aquaculture research and farming industry needs more extensive evaluation. Further studies should include larger exposed populations and should involve clinical validation of questionnaire-based allergic symptom reports, monitoring of Artemia exposure and documenting of the relationship between exposure and clinical symptoms by provocation or exposure tests. At this farm, the ventilatory system and the procedures for handling Artemia, including the use of gloves, have been improved in the hatch room following this study. Further studies on the Artemia allergen are in progress.
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